KeerthiBaskarTamragouriMD

PubMed

• 71 citations
  Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non‐Small Cell Lung Cancer
  Young Kwang Chae, Andrew M. Davis, Sarita Agte, Alan Pan, Nicholas I. Simon, Wade T. Iams, Marcelo Rocha Cruz, Keerthi Tamragouri, Kyunghoon Rhee, Nisha Mohindra, Vict...> ;The Oncologist. 2019 Jun 1
• 5 citations
  Large-Cell Neuroendocrine Carcinoma of the Lung: A Focused Analysis of BRAF Alterations and Case Report of a BRAF Non-V600–Mutated Tumor Responding to Targeted Therapy
  Young Kwang Chae, Keerthi Tamragouri, Jon Chung, Xiaoqi Lin, Vincent A. Miller, Siraj M. Ali, Francis J. Giles> ;JCO Precision Oncology. 2018 Feb 16
• 224 citations
  Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application.
  Young Kwang Chae, Keerthi Ranganath, Peter S. Hammerman, Christos Vaklavas, Nisha Mohindra, Aparna Kalyan, Maria Matsangou, Ricardo Costa, Benedito A. Carneiro, Victor...> ;Oncotarget. 2017 Feb 28
• Angiotensin-Converting Enzyme 2: Enhancing the Degradation of Angiotensin II as a Potential Therapy for Diabetic Nephropathy
  Keerthi Tamragouri, MD> ;ScienceDirect. 2012 Mar
• Join now to see all

Lectures

• Abemaciclib with or without fulvestrant for the treatment of hormone receptor-positive and HER2-negative metastatic breast cancer with disease progression following pr... 
  ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019